• November 2009
Imaging3 is pleased to announce that Dean Janes has submitted the company’s latest response to the FDA today, Monday, November 9, 2009.
In the latest Conference Call Mr. Janes estimated that this document would be sent to the FDA last Friday, November 6th. While the document was ready for submission last Friday Mr. Janes determined that the best course of action was to use this past weekend to ensure that the submission fully met the requirements made by the FDA. We believe this was time well spent and will not materially impact the speed at which the FDA will reply back to the company. Imaging3 will continue to keep investors updated on this important step in bringing the Dominion Volumetric Imaging Scanner (DViS) to market.
If you have any questions, please feel free to contact me by e-mail or directly by calling (800) 900-9729.
Vice President Business Development
Burbank CA 91505
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.